SCHEMBL19731895

SCHEMBL19731895

CC(=O)NC1C(O[C@@H]2OC(C)[C@@H](OC(C)=O)C(OC(C)=O)C2OC(C)=O)[C@H](O[C@@H]2OC(COC(C)=O)[C@H](OC(C)=O)C(OC(C)=O)C2OC(C)=O)C(COC(C)=O)O[C@H]1OC1C(OC(C)=O)[C@H](OC(C)=O)C(COC(C)=O)O[C@@H]1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ POLB P06746 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CYP2D6 P10635 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ CA12 O43570 11/20 0.44
▸ CA1 P00915 11/20 0.44
▸ CA2 P00918 11/20 0.44
▸ CA9 Q16790 11/20 0.44
▸ CA14 Q9ULX7 5/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ PRKCA P17252 1/20 0.41
▸ AKT1 P31749 1/20 0.41
▸ PTK2 Q05397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19731871 0.93 LMNA (0.54) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL12983536 0.91 LMNA (0.50) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL19731870 0.89 LMNA (0.48) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL19731900 0.88 LMNA (0.50) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL19731896 0.88 LMNA (0.42) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL19726212 0.88 LMNA (0.39) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL13991347 0.87 CYP2D6 (0.48) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL21128360 0.87 CYP2D6 (0.48) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL15417845 0.87 LMNA (0.46) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL12871553 0.86 LMNA (0.46) LMNAKMT2APOLBALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336784-B2 Methods for modular synthesis of N-glycans and arrays thereof ACADEMIA SINICA (TW) 2019-07-02 — — US disclosed
US-20170362265-A1 METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF ACADEMIA SINICA (TW) 2017-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362265-A1 METHODS FOR MODULAR SYNTHESIS OF N-GLYCANS AND ARRAYS THEREOF SIGLEC7, SIGLEC9, CD4 LMNA 4279/4885KMT2A 3272/4885POLB 4153/4885
US-10336784-B2 Methods for modular synthesis of N-glycans and arrays thereof SIGLEC7, SIGLEC9, CD4 LMNA 4279/4885KMT2A 3272/4885POLB 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback